Oryzon Genomics
Oryzon Genomics is a clinical stage biopharmaceutical company.
6
Funding Rounds
$40.7m
Money raised
Overview
Oryzon Genomics is a clinical stage biopharmaceutical company.
- Websites:
- Business model: B2B
- Headquarters: Barcelona
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ta**** Ma** | - | - | |
| Ca**** Bu*** | - | - |
Funding series
Funding Series Analysis
The company Oryzon Genomics has raised a total of $17.02m in funding over 6 rounds.
Key Insights:
- Oryzon Genomics Series B round: $17.02m
- Oryzon Genomics Grant (money), December 2016: $800k
- Oryzon Genomics Venture round, July 2019: $20m
- Oryzon Genomics Grant (money), May 2019: $1.5m
- Oryzon Genomics Venture round, December 2018: $1.1m
- Oryzon Genomics Grant (money), April 2017: $300k
Oryzon Genomics Series B round
$17.02m
Oryzon Genomics Grant (money), December 2016
$800k
Oryzon Genomics Venture round, July 2019
$20m
Oryzon Genomics Grant (money), May 2019
$1.5m
Oryzon Genomics Venture round, December 2018
$1.1m
Oryzon Genomics Grant (money), April 2017
$300k
Industries
Oryzon Genomics is active in the following industries: